Prescription behaviour of short-acting ß2-agonists in Switzerland

C. Schuoler (Baar, Switzerland), C. Steurer-Stey (Zurich, Switzerland), E. Ullmer (Bern, Switzerland), R. Providoli (Sierre, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), G. Pendl (Baar, Switzerland)

Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Session: Inhaled corticosteroids and bronchodilator studies in asthma
Session type: E-poster session
Number: 2640
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Schuoler (Baar, Switzerland), C. Steurer-Stey (Zurich, Switzerland), E. Ullmer (Bern, Switzerland), R. Providoli (Sierre, Switzerland), V. Chicherov (Rotkreuz, Switzerland), M. Korobeynikova (Rotkreuz, Switzerland), S. Wetzel (Rotkreuz, Switzerland), G. Pendl (Baar, Switzerland). Prescription behaviour of short-acting ß2-agonists in Switzerland. 2640

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK
Source: Eur Respir J, 55 (6) 1902363; 10.1183/13993003.02363-2019
Year: 2020



Regional differences in the prescription of antiasthmatic drugs in the Federal Republic of Germany
Source: Eur Respir J 2001; 18: Suppl. 33, 442s
Year: 2001

Real-life use of long-acting antimuscarinic agents following their approval for COPD treatment
Source: Eur Respir J 2015; 45: 260-262
Year: 2015


Oral corticosteroid prescription patterns in asthma care in Italy
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019


SABA overuse in the Portuguese prescription database
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


Prescription of antitussives in asthma: A cross-sectional study in primary care in France and in Italy
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012

Changes in inhaled anticholinergic prescription pattern in a Spanish health department
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007


Late Breaking Abstract - Overestimation of asthma control and misperception of short-acting ß2-agonists (SABA) use among physicians in Poland
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020


Late Breaking Abstract - Overprescription of short-acting beta2-agonists in asthma management? Pharmacy reports from 91,673 patients in Poland
Source: International Congress 2019 – New towards old therapies in airway diseases
Year: 2019



Effect of combined inhaled corticosteroid-formoterol therapy on short-acting beta2-agonist use in Poland: a retrospective analysis of pharmacy reports
Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma
Year: 2020


Prescription rates for various classes of COPD & asthma medication in Turkey
Source: Eur Respir J 2001; 18: Suppl. 33, 425s
Year: 2001

The DACCORD study: Real-life COPD outpatient treatment with long-acting bronchodilators in Germany
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013

Identification of asthma level of control using administrative data of short-acting beta-agonist inhalers purchase
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016

Prescribing patterns of antiasthma medication in children and adolescents in primary care in France.
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020


Prescription of inhaled corticosteroids for COPD in general practice in Denmark – changes after participating in an educational programme
Source: Annual Congress 2008 - Management of COPD
Year: 2008


Use of short-acting beta-2 agonists (SABA) and exacerbations in a nationwide Swedish asthma cohort (HERA)
Source: International Congress 2019 – Asthma treatment: cohorts and real-world studies
Year: 2019

The drug costs associated with COPD prescription medicine in Denmark
Source: Annual Congress 2012 - Looking at the cost effectiveness of asthma and COPD treatment by novel drugs and improved management
Year: 2012


Survey of dyspnoea in COPD patients on medication and preemptive use of a short-acting β-2 agonist
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009


Astro-Lab project: Assessment of the safety of long-acting beta agonists (LABAs) in asthma by combining health-care databases and direct patient follow-up: Description of the patient pattern in France and in the United-Kingdom (UK)
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013


Monitoring adherence to treatment regimen of inhaled medication use in a clinical trial with an investigational eFlow nebulizer (eTrack)
Source: International Congress 2017 – Medical education, web and internet
Year: 2017